Literature DB >> 7075735

Radioresistance in cells with high content of metallothionein.

A Bakka, A S Johnsen, L Endresen, H E Rugstad.   

Abstract

An endogenous cytoplasmic protein, metallothionein (MT) apparently gave rise to radioresistance in 2 different cell lines. A dose reduction factor of 1.9 was achieved in MT-containing cells. MT accounted for a 3-4 fold increase of total sulfhydryl groups in the resistant cell strains, compared to the non-resistant lines from which they were derived. The protein is rich in cysteine (30%), an amino acid known to give radioprotection when administered exogenously. Glutathione levels and cell-cycle phase distribution showed no marked difference between resistant and corresponding non-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075735     DOI: 10.1007/bf01949406

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  11 in total

1.  Cadmium resistance and content of cadmium-binding protein in cultured human cells.

Authors:  N E Rugstad; T Norseth
Journal:  Nature       Date:  1975-09-11       Impact factor: 49.962

2.  [ON CADMIUM IN NORMAL HUMAN KIDNEYS WITH A REPORT ON THE ISOLATION OF METALLOTHIONEINE FROM CADMIUM-EXPOSED RABBIT LIVERS].

Authors:  M PISCATOR
Journal:  Nord Hyg Tidskr       Date:  1964

3.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

4.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

Authors:  F Tietze
Journal:  Anal Biochem       Date:  1969-03       Impact factor: 3.365

5.  Human hepatic metallothioneins.

Authors:  R H Bühler; J H Kägi
Journal:  FEBS Lett       Date:  1974-02-15       Impact factor: 4.124

6.  Protection of carbon tetrachloride-induced hepatotoxicity by zinc: role of metallothionein.

Authors:  S Z Cagen; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1979-10       Impact factor: 4.219

7.  Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein.

Authors:  A Bakka; L Endresen; A B Johnsen; P D Edminson; H E Rugstad
Journal:  Toxicol Appl Pharmacol       Date:  1981-11       Impact factor: 4.219

8.  Metabolism of zinc and copper in the neonate: changes in the concentrations and contents of thionein-bound Zn and Cu with age in the livers of the newborn of various mammalian species.

Authors:  A Bakka; M Webb
Journal:  Biochem Pharmacol       Date:  1981-04-01       Impact factor: 5.858

9.  Uptake and egress of cadmium in cultures of cadmium-resistant and the corresponding "wild-type" cells.

Authors:  A Bakka; H E Rugstad
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-02

10.  Cadmium resistance and content of cadmium-binding protein in two enzyme-deficient mutants of mouse fibroblasts (L-cells).

Authors:  H E Rugstad; T Norseth
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

View more
  13 in total

1.  Use of metallothioneins as biomarkers for environmental quality assessment in the Gulf of Gabès (Tunisia).

Authors:  Rim Ladhar-Chaabouni; Monia Machreki-Ajmi; Amel Hamza-Chaffai
Journal:  Environ Monit Assess       Date:  2011-05-25       Impact factor: 2.513

2.  Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.

Authors:  P Farnworth; B Hillcoat; I Roos
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Transient response of amplified metallothionein genes in CHO cells to induction by alpha interferon.

Authors:  S Morris; P C Huang
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.

Authors:  M Satoh; A Naganuma; N Imura
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

Authors:  T P Mulder; H W Verspaget; A R Janssens; P A de Bruin; A S Peña; C B Lamers
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

6.  Effect of superoxide dismutase, allopurinol and glucocorticoids on liver and lung metallothionein induction by endotoxin in the rat.

Authors:  M Giralt; A Blanquez; J Avila; J Hidalgo
Journal:  Biometals       Date:  1993       Impact factor: 2.949

7.  Interleukin 1 regulates human metallothionein gene expression.

Authors:  M Karin; R J Imbra; A Heguy; G Wong
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

8.  Metallothionein protects DNA from oxidative damage.

Authors:  L S Chubatsu; R Meneghini
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents.

Authors:  B Kaina; H Lohrer; M Karin; P Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 10.  Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy.

Authors:  F Doz; N Roosen; M L Rosenblum
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.